Key Record Dates Identifier: NCT02933944
Brief Title: Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer

First Submitted : September 8, 2016
First Submitted that Met QC Criteria : October 13, 2016
First Posted : October 14, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : June 13, 2019
Last Update Posted : June 14, 2019